Segall Bryant & Hamill’s NEVRO CORP. NVRO Stock Holding History

Segall Bryant & Hamill’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-13,201	Closed	-$1.05M	–	884
2018 Q2	$1.05M	Buy	+13,201	New	+$1.1M	0.02%	532

Other funds holding NVRO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Segall Bryant & Hamill's NVRO Position: Q3 2018 in Review

Segall Bryant & Hamill sold out of NEVRO CORP. (NVRO) in Q3 2018, closing a stake of 13,201 shares — an estimated $1.05M sold.

Segall Bryant & Hamill first reported a position in NVRO in Q2 2018 and held it in 1 quarter. The position peaked at $1.05M in Q2 2018. 171 funds tracked by Wall St. Rank hold NVRO as of Q3 2018.

Segall Bryant & Hamill reported no remaining NEVRO CORP. position as of Q3 2018 after selling out during the quarter.
Segall Bryant & Hamill sold 13,201 NEVRO CORP. shares in Q3 2018, an estimated $1.05M.
Segall Bryant & Hamill first reported a position in NEVRO CORP. in Q2 2018 and held it in 1 quarter.
Segall Bryant & Hamill's NEVRO CORP. position peaked at $1.05M in Q2 2018.
171 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2018.

Based on Segall Bryant & Hamill's 13F filing for Q3 2018, filed 14 Nov 2018.